FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen
Episode Summary
FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.